🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
Standard placebo-controlled, double-blind study design (TEV-50717 \[low dos...
Status
Completed
Location
Teva Investigational Site 060-0160
Start Date
2018-05-31
Trial ID
NCT03571256
This is an otherwise open-label, single-arm study that includes a 2-week, d...
Status
Terminated
Location
Teva Investigational Site 046-0104
Start Date
2018-05-25
Trial ID
NCT03567291
CP (cerebral palsy) refers to a group of neurological disorders that appear...
Status
Completed
Location
Teva Investigational Site 14137
Start Date
2019-08-06
Trial ID
NCT03813238
The purpose of this study is to evaluate the long-term safety, tolerability...
Status
Completed
Location
Teva Investigational Site 145
Start Date
2014-10-20
Trial ID
NCT02198794
This is a study to evaluate the efficacy and safety of deutetrabenazine (TE...
Status
Completed
Location
Teva Investigational Site 046-0104
Start Date
2018-02-05
Trial ID
NCT03452943
Study TV50717-CNS-30081 is a 55-week study in which participants who have s...
Status
Terminated
Location
Teva Investigational Site 14137
Start Date
2020-02-04
Trial ID
NCT04200352
Treatments Being Tested